Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenaline plus placebo vs noradrenaline plus terlipressin in septic shock
2020-005756-37Phase 3Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jul 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in septic shock comparing Norepinephrine plus terlipressin with Norepinephrine plus placebo (2 arms). Primary endpoint: Reduction of organ failure evaluated by SOFA scale. Started Jul 2021; status: active.
02
Drugs
terlipressin
03
Conditions
septic shock
Beyond the preview
Go deeper on 2020-005756-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005756-37.